The pcr packaging for pharma and otc market is projected to grow from USD 2,360.0 million in 2026 to USD 6,946.5 million by 2036, at a CAGR of 11.4%. Bottles, blisters & jars will dominate with a 49.0% market share, while fda / eu gmp-validated pcr will lead the compliance technology segment with a 54.0% share.